S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
NASDAQ:HRTS

Tema Cardiovascular and Metabolics ETF (HRTS) Price, Holdings, & News

$34.89
+1.06 (+3.13%)
(As of 03/1/2024 ET)
Today's Range
$34.02
$35.01
50-Day Range
$30.15
$34.89
52-Week Range
$26.26
$35.29
Volume
36,048 shs
Average Volume
28,358 shs
Market Capitalization
$40.47 million
Assets Under Management
$47.90 million
Dividend Yield
N/A
Net Expense Ratio
0.75%

HRTS Stock Price History

HRTS ETF News Headlines

Tema ETFs: A Better Way to Invest in Life Sciences
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
The Truth HRTS
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Tema Cardiovascular and Metabolic ETF (HRTS)
See More Headlines
Receive HRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tema Cardiovascular and Metabolics ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Tema Global
Fund Name
Tema Cardiovascular and Metabolics ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:HRTS
Inception Date
11/20/2023
Fund Manager
David Song, Yuri Khodjamirian
Previous Symbol
NASDAQ:HRTS
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
43

Fund Statistics

Assets Under Management
$47.90 million
Average Daily Volume
$0.00
Discount/Premium
0.10%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Tema Global Limited
Custodian
U.S. Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
U.S. Bancorp Fund Services, LLC
Trustee
N/A
Lead Market Maker
Virtu Financial

Miscellaneous

Beta
N/A
Creation Unit
10,000
Creation Fee
$500.00
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Tema Cardiovascular and Metabolics ETF Expenses

TypeHRTSTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.99%0.57%0.54%0.48%0.51%
Other Expenses0.00%0.72%0.55%0.33%0.58%
Total Expense0.99%0.72%0.70%0.57%0.70%
Fee Waiver-0.24%-0.77%-0.55%-0.20%-0.57%
Net Expense0.75%0.59%0.60%0.53%0.58%

Tema Cardiovascular and Metabolics ETF (HRTS) Exposure

HRTS Sector Exposure

HRTS Industry Exposure















HRTS ETF - Frequently Asked Questions

How have HRTS shares performed in 2024?

Tema Cardiovascular and Metabolics ETF's stock was trading at $30.61 at the beginning of the year. Since then, HRTS shares have increased by 14.0% and is now trading at $34.89.
View the best growth stocks for 2024 here
.

What does HRTS invest in?

Tema Cardiovascular and Metabolics ETF is a equity fund issued by Tema Global. HRTS focuses on theme investments. The fund's investments total to approximately $47.90 million assets under management.

What is the management fee for Tema Cardiovascular and Metabolics ETF?

Tema Cardiovascular and Metabolics ETF's management fee is 0.99% and has no other recorded expenses. However, HRTS has a fee waiver of -0.24% to reimburse the expenses. The net expense ratio for HRTS is 0.75%.

How do I buy shares of Tema Cardiovascular and Metabolics ETF?

Shares of HRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HRTS) was last updated on 3/3/2024 by MarketBeat.com Staff